{
    "info": {
        "nct_id": "NCT06364176",
        "official_title": "Targeting Inflammation With Losartan to Improve Response to Modulator Therapy in Cystic Fibrosis",
        "inclusion_criteria": "* Established diagnosis of cystic fibrosis\n* Age 12 years and older\n* Stable use of elexacaftor/tezacaftor/ivacaftor for 90 days prior to enrollment\n* Sweat chloride concentration 50 mmol/L or greater while on elexacaftor/tezacaftor/ivacaftor\nHealthy volunteers allowed\nMust have minimum age of 12 Years",
        "exclusion_criteria": "* Prior lung transplant\n* BMI <18\n* CF pulmonary exacerbation requiring hospitalization or intravenous antibiotics in the preceding 30 days\n* Systemic corticosteroid or regular non-steroidal anti-inflammatory use in the preceding 30 days\n* Chronic use of angiotensin receptor blockers or angiotensin converting enzyme inhibitors\n* Concomitant use of medications known to interact with losartan, including aliskiren\n* Chronic renal insufficiency (creatinine clearance <45 ml/min)\n* Pregnancy or lactation\n* Inability or unwillingness to comply with approved contraceptive method during the study period (females of childbearing age)\n* In the opinion of the investigator any severe or acute or chronic condition or laboratory abnormality that may increase the risk associated with trial participation or make the participant inappropriate for enrollment\n* Participation in another interventional trial that, in the opinion of the investigator, has the potential to affect the primary outcome",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "* Established diagnosis of cystic fibrosis",
            "criterions": [
                {
                    "exact_snippets": "Established diagnosis of cystic fibrosis",
                    "criterion": "cystic fibrosis",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Age 12 years and older",
            "criterions": [
                {
                    "exact_snippets": "Age 12 years and older",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum value",
                            "expected_value": {
                                "operator": ">=",
                                "value": 12,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Stable use of elexacaftor/tezacaftor/ivacaftor for 90 days prior to enrollment",
            "criterions": [
                {
                    "exact_snippets": "Stable use of elexacaftor/tezacaftor/ivacaftor",
                    "criterion": "elexacaftor/tezacaftor/ivacaftor use",
                    "requirements": [
                        {
                            "requirement_type": "stability",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "for 90 days prior to enrollment",
                    "criterion": "elexacaftor/tezacaftor/ivacaftor use duration",
                    "requirements": [
                        {
                            "requirement_type": "duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 90,
                                "unit": "days"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Sweat chloride concentration 50 mmol/L or greater while on elexacaftor/tezacaftor/ivacaftor",
            "criterions": [
                {
                    "exact_snippets": "Sweat chloride concentration 50 mmol/L or greater",
                    "criterion": "sweat chloride concentration",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 50,
                                "unit": "mmol/L"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "while on elexacaftor/tezacaftor/ivacaftor",
                    "criterion": "elexacaftor/tezacaftor/ivacaftor therapy",
                    "requirements": [
                        {
                            "requirement_type": "current use",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 12 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 12 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 12,
                                "unit": "Years"
                            }
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "* BMI <18",
            "criterions": [
                {
                    "exact_snippets": "BMI <18",
                    "criterion": "BMI",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "operator": "<",
                                "value": 18,
                                "unit": ""
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* In the opinion of the investigator any severe or acute or chronic condition or laboratory abnormality that may increase the risk associated with trial participation or make the participant inappropriate for enrollment",
            "criterions": [
                {
                    "exact_snippets": "any severe or acute or chronic condition or laboratory abnormality that may increase the risk associated with trial participation or make the participant inappropriate for enrollment",
                    "criterion": "severe, acute, or chronic condition or laboratory abnormality",
                    "requirements": [
                        {
                            "requirement_type": "investigator opinion of risk/inappropriateness",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Concomitant use of medications known to interact with losartan, including aliskiren",
            "criterions": [
                {
                    "exact_snippets": "Concomitant use of medications known to interact with losartan, including aliskiren",
                    "criterion": "concomitant use of interacting medications",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "interaction_with",
                            "expected_value": [
                                "losartan"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Participation in another interventional trial that, in the opinion of the investigator, has the potential to affect the primary outcome",
            "criterions": [
                {
                    "exact_snippets": "Participation in another interventional trial",
                    "criterion": "participation in another interventional trial",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "that, in the opinion of the investigator, has the potential to affect the primary outcome",
                    "criterion": "potential to affect the primary outcome (of another interventional trial)",
                    "requirements": [
                        {
                            "requirement_type": "potential to affect primary outcome",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "investigator opinion",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* CF pulmonary exacerbation requiring hospitalization or intravenous antibiotics in the preceding 30 days",
            "criterions": [
                {
                    "exact_snippets": "CF pulmonary exacerbation requiring hospitalization ... in the preceding 30 days",
                    "criterion": "CF pulmonary exacerbation requiring hospitalization",
                    "requirements": [
                        {
                            "requirement_type": "recency",
                            "expected_value": {
                                "operator": "<=",
                                "value": 30,
                                "unit": "days"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "CF pulmonary exacerbation requiring ... intravenous antibiotics in the preceding 30 days",
                    "criterion": "CF pulmonary exacerbation requiring intravenous antibiotics",
                    "requirements": [
                        {
                            "requirement_type": "recency",
                            "expected_value": {
                                "operator": "<=",
                                "value": 30,
                                "unit": "days"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Pregnancy or lactation",
            "criterions": [
                {
                    "exact_snippets": "Pregnancy",
                    "criterion": "pregnancy",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "lactation",
                    "criterion": "lactation",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Prior lung transplant",
            "criterions": [
                {
                    "exact_snippets": "Prior lung transplant",
                    "criterion": "lung transplant",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Systemic corticosteroid or regular non-steroidal anti-inflammatory use in the preceding 30 days",
            "criterions": [
                {
                    "exact_snippets": "Systemic corticosteroid ... use in the preceding 30 days",
                    "criterion": "systemic corticosteroid use",
                    "requirements": [
                        {
                            "requirement_type": "recency",
                            "expected_value": {
                                "operator": "<=",
                                "value": 30,
                                "unit": "days"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "regular non-steroidal anti-inflammatory use in the preceding 30 days",
                    "criterion": "regular non-steroidal anti-inflammatory use",
                    "requirements": [
                        {
                            "requirement_type": "recency",
                            "expected_value": {
                                "operator": "<=",
                                "value": 30,
                                "unit": "days"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Inability or unwillingness to comply with approved contraceptive method during the study period (females of childbearing age)",
            "criterions": [
                {
                    "exact_snippets": "Inability or unwillingness to comply with approved contraceptive method during the study period (females of childbearing age)",
                    "criterion": "compliance with approved contraceptive method",
                    "requirements": [
                        {
                            "requirement_type": "compliance",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "(females of childbearing age)",
                    "criterion": "sex and reproductive status",
                    "requirements": [
                        {
                            "requirement_type": "sex",
                            "expected_value": "female"
                        },
                        {
                            "requirement_type": "reproductive status",
                            "expected_value": "childbearing age"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Chronic renal insufficiency (creatinine clearance <45 ml/min)",
            "criterions": [
                {
                    "exact_snippets": "Chronic renal insufficiency",
                    "criterion": "chronic renal insufficiency",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "creatinine clearance <45 ml/min",
                    "criterion": "creatinine clearance",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 45,
                                "unit": "ml/min"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Chronic use of angiotensin receptor blockers or angiotensin converting enzyme inhibitors",
            "criterions": [
                {
                    "exact_snippets": "Chronic use of angiotensin receptor blockers",
                    "criterion": "angiotensin receptor blocker use",
                    "requirements": [
                        {
                            "requirement_type": "chronic use",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Chronic use of ... angiotensin converting enzyme inhibitors",
                    "criterion": "angiotensin converting enzyme inhibitor use",
                    "requirements": [
                        {
                            "requirement_type": "chronic use",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}